Navigation mit Access Keys

Main Content

Main Content

January 14, 2019

Engineered T cells promote long-term organ transplant acceptance

Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens...

January 07, 2019

A springboard into research for Bachelor students

With the "Biozentrum Research Summer" program, Bachelor students in the sciences again have the opportunity to immerse themselves in a cutting-edge...

December 20, 2018

“Science” honors Alex Schier’s research studies as “Breakthrough of the Year 2018”

Publications of Prof. Alex Schier from the Biozentrum, University of Basel, and Harvard University were named "Breakthrough of the Year 2018" by the...

December 20, 2018

Bacteria rely on classic business model

The pneumonia causing pathogen Pseudomonas aeruginosa has developed a twin-track strategy to colonize its host. It generates two different cells –...

December 20, 2018

First Innosuisse project at the Biozentrum

Dr. Stefan Imseng and Dr. Asier González are conducting a new study at the Biozentrum of the University of Basel to develop a novel drug for the...

December 11, 2018

Lethal combination: Drug cocktail turns off the “juice” to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by the team of Prof....

December 06, 2018

Mike Hall awarded the 2019 Charles Rodolphe Brupbacher Award for Cancer Research

For his achievements in cancer research, the cell biologist Prof. Michael N. Hall, from the Biozentrum of the University of Basel, has been awarded...

November 28, 2018

Biozentrum PhD Fellowships: Application deadline December 15

The Biozentrum has launched an additional winter call for its prestigious and much sought after PhD Fellowships. Ambitious and highly motivated young...

November 09, 2018

T3 Pharmaceuticals wins prestigious Falling Walls Venture Award

T3 Pharma, a biotech start-up company of the Biozentrum, University of Basel, with a focus on immuno-oncology, has been named “2018 Science Start-Up...